In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

Br J Cancer · 2013 · PMC3619253 · PMID 23412107

Europe PMC DOI

hedged sentence

0.1780

closest p · 3.6× alpha

0.1780

boldest claim

The sentences

did not reach statistical significanceP =0.178not close (p > 0.1)

Patients with a positive pShift had an improvement in OS that did not reach statistical significance ( P =0.178).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.